Holdings
Sands Capital Alternatives, LLC
As of Jun 30, 2026, Sands Capital Alternatives, LLC reported 23 positions worth US$608M. Largest: Alamar Biosciences, Inc., Nu Holdings Ltd. and Klaviyo, Inc. Series A. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Alamar Biosciences, Inc. | 4.23M | US$115M | new | Jun 30, 2026 |
| Nu Holdings Ltd. | 7.09M | US$94.8M | +557K | Jun 30, 2026 |
| Klaviyo, Inc. Series A | 3.93M | US$59.3M | +278K | Jun 30, 2026 |
| Beta Bionics, Inc. | 3.71M | US$58.1M | no change | Jun 30, 2026 |
| Spyglass Pharma, Inc. | 2.5M | US$55.7M | no change | Jun 30, 2026 |
| Inhibikase Therapeutics, Inc. | 13M | US$26.4M | no change | Jun 30, 2026 |
| Doordash, Inc. | 128K | US$23.5M | +16,331 | Jun 30, 2026 |
| Coupang, Inc. | 1.33M | US$23.1M | +317K | Jun 30, 2026 |
| Datadog, Inc. | 80,851 | US$21.1M | −4,942 | Jun 30, 2026 |
| Bioage Labs, Inc. | 786K | US$19.3M | no change | Jun 30, 2026 |